Meridian launches C. diff. test in Europe; Abbott, Boston Sci tops in DES market;

> Meridian Bioscience has launched a new Clostridium difficile rapid test, ImmunoCard C. difficile GDH in Europe. Meridian release

> Abbott Laboratories and Boston Scientific are the top players in the U.S. drug-eluting stent market, together staking claim to more than half of all DES revenues. News

> Boston Scientific has launched a clinical education program and online resource center for healthcare providers to enhance their knowledge and awareness of spinal cord stimulation technology, procedures and techniques. Boston Scientific release

> Medtronic has reported the first use in Latin America of renal denervation with the company's Symplicity catheter system to treat a patient with resistant hypertension. Medtronic release

> Toronto-based medical laser developer Hamilton Thorne is proposing a private placement of 12 million common shares worth about $3 million. Story

And Finally... GE Healthcare has released Centricity Advance - Mobile, an iPad/iPhone version of its EMR for medical practices with 10 or fewer physicians. With the gadget, prescription refills can be filled out and emailed questions can be answered directly from the app. Item

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.